Search - tctmd.com

Displaying 221 - 240 of 603

Sort: Relevancy | Date

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Industry News

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

December 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Daily News

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

L.A. McKeown

November 20, 2020

News Conference News AHA 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

Caitlin E. Cox

November 20, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Todd Neale

November 15, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Todd Neale

October 29, 2020

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

Caitlin E. Cox

October 27, 2020

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 322: Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Presenter: Klio Konstantinou

October 14, 2020

Presentation TCT 2020

TCT 392: Prognostic Impact of Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance After Percutaneous Coronary Intervention

Presenter: Christopher Wong

October 14, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Daily News

Unwarranted Stress Testing Before Knee, Hip Surgery Is Declining

Caitlin E. Cox

October 07, 2020

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

L.A. McKeown

September 29, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Daily News

Colchicine Shows Potential in Malignant Pericardial Effusion

Caitlin E. Cox

September 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

Advertisement

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

TCTMD’s Top 10 Most Popular Stories for November 2020

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

New Review Urges Rethink of Cardiogenic Shock Care

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 322: Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

TCT 392: Prognostic Impact of Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance After Percutaneous Coronary Intervention

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Unwarranted Stress Testing Before Knee, Hip Surgery Is Declining

Young Women With AMICS: High Risk, Inadequate Care

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Colchicine Shows Potential in Malignant Pericardial Effusion

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content